Zions Bancorporation’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $26K | Buy |
160
+6
| +4% | +$982 | ﹤0.01% | 478 |
|
|
2024
Q3 | $25.1K | Sell |
154
-9
| -6% | -$1.33K | ﹤0.01% | 489 |
|
|
2024
Q2 | $22.2K | Sell |
163
-29
| -15% | -$4.03K | ﹤0.01% | 531 |
|
|
2024
Q1 | $29.4K | Sell |
192
-1
| -0.5% | -$149 | ﹤0.01% | 496 |
|
|
2023
Q4 | $27.5K | Sell |
193
-36
| -16% | -$4.8K | ﹤0.01% | 488 |
|
|
2023
Q3 | $30K | Sell |
229
-8
| -3% | -$1.22K | ﹤0.01% | 452 |
|
|
2023
Q2 | $37.7K | Sell |
237
-18,490
| -99% | -$2.98M | ﹤0.01% | 427 |
|
|
2023
Q1 | $2.96M | Sell |
18,727
-8,160
| -30% | -$1.22M | 0.25% | 71 |
|
|
2022
Q4 | $3.77M | Buy |
26,887
+2,316
| +9% | +$329K | 0.3% | 48 |
|
|
2022
Q3 | $3.15M | Buy |
24,571
+1,928
| +9% | +$278K | 0.33% | 50 |
|
|
2022
Q2 | $3.19M | Buy |
22,643
+13,060
| +136% | +$1.87M | 0.32% | 54 |
|
|
2022
Q1 | $1.33M | Buy |
9,583
+9,452
| +7,215% | +$1.45M | 0.12% | 117 |
|
|
2021
Q4 | $23K | Buy |
131
+17
| +15% | +$2.83K | ﹤0.01% | 595 |
|
|
2021
Q3 | $19K | Buy |
114
+17
| +18% | +$2.93K | ﹤0.01% | 622 |
|
|
2021
Q2 | $17K | Buy |
97
+28
| +41% | +$5.11K | ﹤0.01% | 622 |
|
|
2021
Q1 | $13K | Sell |
69
-12
| -15% | -$2.31K | ﹤0.01% | 641 |
|
|
2020
Q4 | $16K | Sell |
81
-4
| -5% | -$828 | ﹤0.01% | 587 |
|
|
2020
Q3 | $18K | Buy |
85
+8
| +10% | +$1.78K | ﹤0.01% | 552 |
|
|
2020
Q2 | $17K | Hold |
77
| – | – | ﹤0.01% | 524 |
|
|
2020
Q1 | $13K | Sell |
77
-190
| -71% | -$31.4K | ﹤0.01% | 535 |
|
|
2019
Q4 | $41K | Buy |
267
+106
| +66% | +$15.8K | 0.01% | 445 |
|
|
2019
Q3 | $24K | Buy |
161
+1
| +0.6% | +$158 | ﹤0.01% | 554 |
|
|
2019
Q2 | $24K | Sell |
160
-17
| -10% | -$2.6K | ﹤0.01% | 509 |
|
|
2019
Q1 | $28K | Buy |
+177
| New | +$27.5K | ﹤0.01% | 517 |
|
|
2018
Q4 | – | Sell |
-176
| Closed | -$26K | – | 553 |
|
|
2018
Q3 | $26K | Buy |
+176
| New | +$25K | 0.01% | 433 |
|
|
2018
Q2 | – | Sell |
-264
| Closed | -$35K | – | 490 |
|
|
2018
Q1 | $35K | Buy |
+264
| New | +$35.5K | 0.01% | 290 |
|
|
2017
Q4 | – | Sell |
-451
| Closed | -$60K | – | 680 |
|
|
2017
Q3 | $60K | Buy |
451
+315
| +232% | +$42.3K | 0.01% | 529 |
|
|
2017
Q2 | $18K | Sell |
136
-856
| -86% | -$116K | ﹤0.01% | 293 |
|
|
2017
Q1 | $134K | Buy |
992
+53
| +6% | +$6.87K | 0.03% | 137 |
|
|
2016
Q4 | $113K | Sell |
939
-833
| -47% | -$98.2K | 0.02% | 157 |
|
|
2016
Q3 | $221K | Buy |
1,772
+1,633
| +1,175% | +$214K | 0.04% | 111 |
|
|
2016
Q2 | $19K | Sell |
139
-33
| -19% | -$4.28K | ﹤0.01% | 338 |
|
|
2016
Q1 | $21K | Hold |
172
| – | – | ﹤0.01% | 386 |
|
|
2015
Q4 | $22K | Sell |
172
-1,069
| -86% | -$133K | ﹤0.01% | 340 |
|
|
2015
Q3 | $89K | Buy |
+1,241
| New | +$139K | 0.02% | 152 |
|
|
2015
Q2 | – | Sell |
-97
| Closed | -$11K | – | 349 |
|
|
2015
Q1 | $11K | Buy |
+97
| New | +$10.5K | ﹤0.01% | 501 |
|
Other funds holding CLX
Zions Bancorporation's CLX Position: Q4 2024 in Review
Zions Bancorporation increased its Clorox (CLX) stake by 3.9% in Q4 2024, buying an estimated $982 and bringing the position to 160 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #478.
Zions Bancorporation first reported a position in CLX in Q1 2015 and has held it in 36 quarters since. The position peaked at $3.77M in Q4 2022. 1,223 funds tracked by Wall St. Rank hold CLX as of Q4 2024.
- Zions Bancorporation held 160 shares of Clorox worth $26K as of Q4 2024.
- Zions Bancorporation bought 6 Clorox shares in Q4 2024, an estimated $982.
- Clorox made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #478 holding.
- Zions Bancorporation first reported a position in Clorox in Q1 2015 and has held it in 36 quarters since.
- Zions Bancorporation's Clorox position peaked at $3.77M in Q4 2022.
- 1,223 funds tracked by Wall St. Rank held Clorox as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.